Profile data is unavailable for this security.
About the company
Iconovo AB is a Sweden-based company, which offers inhalation solutions for pharmaceutical companies. Solutions are based on the Company’s device platforms and include formulation, analytical testing and documentation. Iconovo Ab develops products, which are a part of device family and include: ICOres, reservoir devices, ICOone, disposable unit-dose devices, ICOcap, capsule-based devices and ICOpre, pre-metered devices. Moreover, the Company offers programs, which include development of generic inhalation products, where the products are registered based on therapeutic equivalence; development of inhalation products based on a generic application programming interface (API) and new chemical entity (NCE); as well as phase I-II clinical trials using ICOone.
- Revenue in SEK (TTM)1.11m
- Net income in SEK-43.36m
- Incorporated2013
- Employees13.00
- LocationIconovo ABC/O Medicon Village AbLUND 223 62SwedenSWE
- Phone+46 462756777
- Websitehttps://www.iconovo.se/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Episurf Medical AB | 16.10m | -58.10m | 59.73m | 18.00 | -- | 1.26 | -- | 3.71 | -0.0533 | -0.0533 | 0.0138 | 0.0286 | 0.2043 | -- | 4.54 | 894,444.40 | -72.97 | -47.42 | -86.27 | -52.18 | -- | -- | -357.14 | -701.12 | 1.41 | -579.00 | 0.0935 | -- | 22.90 | 18.13 | 23.42 | -- | 7.81 | -- |
| Kontigo Care AB | 29.13m | -2.07m | 59.93m | 10.00 | -- | 1.19 | 16.56 | 2.06 | -0.0589 | -0.0589 | 0.8262 | 1.43 | 0.4487 | -- | 7.97 | -- | -3.19 | 0.296 | -3.98 | 0.4064 | 125.51 | 129.99 | -7.12 | 0.4638 | -- | -- | 0.00 | -- | -3.66 | 7.41 | -367.61 | -- | 17.15 | -- |
| Redsense Medical AB (publ) | 30.67m | 302.00k | 60.02m | 4.00 | 182.23 | 1.67 | 101.56 | 1.96 | 0.02 | 0.02 | 1.86 | 2.18 | 0.7697 | 1.96 | 6.61 | 6,134,600.00 | 0.7578 | -14.28 | 0.8514 | -15.86 | 61.45 | 68.85 | 0.9846 | -32.79 | 4.69 | -- | 0.00 | -- | 12.85 | 16.26 | 107.58 | -- | -53.01 | -- |
| Scandinavian ChemoTech AB | 11.68m | -8.70m | 82.43m | 1.00 | -- | 14.32 | -- | 7.06 | -0.3727 | -0.3727 | 0.5003 | 0.2653 | 0.727 | 0.5917 | 2.66 | 1,946,333.00 | -54.15 | -92.70 | -83.07 | -131.46 | 82.15 | 104.65 | -74.49 | -866.06 | 0.861 | -5.61 | 0.00 | -- | 132.67 | 63.85 | 34.96 | -- | -59.68 | -- |
| BibbInstruments AB | 402.00k | -14.61m | 85.55m | 4.00 | -- | 2.27 | -- | 212.82 | -0.3677 | -0.3677 | 0.0102 | 0.9238 | 0.0109 | -- | 0.4997 | 100,500.00 | -39.52 | -36.87 | -44.26 | -40.54 | 16.42 | 17.99 | -3,634.33 | -14,348.68 | 2.96 | -- | -- | -- | -- | 10.72 | -14.97 | -- | -0.0892 | -- |
| SyntheticMR AB (publ) | 57.05m | -54.93m | 97.37m | 41.00 | -- | 0.6599 | -- | 1.71 | -0.9057 | -0.9057 | 0.9467 | 1.65 | 0.3678 | -- | 0.8733 | 1,391,415.00 | -35.42 | -7.92 | -51.34 | -10.51 | 10.41 | 56.07 | -96.28 | -14.37 | -- | -8.73 | 0.0450 | -- | 2.47 | 3.20 | -241.50 | -- | 7.37 | -- |
| Bioretec Oy | 37.46m | -92.39m | 98.26m | 60.00 | -- | 0.943 | -- | 2.62 | -0.29 | -0.29 | 0.1177 | 0.3171 | 0.3032 | 0.5513 | 2.23 | 58,500.00 | -74.77 | -62.68 | -86.25 | -80.54 | 57.61 | 69.60 | -246.61 | -155.57 | 2.99 | -6.57 | 0.0139 | -- | -22.48 | 18.63 | -105.54 | -- | -- | -- |
| Observe Medical ASA | 15.89m | -117.12m | 103.29m | 4.00 | -- | 4.19 | -- | 6.50 | -26.57 | -26.57 | 3.29 | 0.1909 | 0.1118 | 2.87 | 8.29 | 3,350,800.00 | -82.38 | -42.22 | -205.00 | -64.14 | 6.24 | 30.17 | -737.14 | -327.97 | 0.1175 | -3.72 | 0.9572 | -- | -33.85 | 153.47 | -98.73 | -- | -2.97 | -- |
| Iconovo AB | 1.11m | -43.36m | 108.67m | 13.00 | -- | 0.5085 | -- | 98.35 | -1.31 | -1.31 | 0.0287 | 2.22 | 0.008 | -- | 2.70 | -- | -31.34 | -31.04 | -34.30 | -34.58 | 1,042.35 | 198.84 | -3,924.34 | -469.09 | -- | -171.76 | 0.0305 | -- | -62.34 | -42.64 | -5.41 | -- | 2.30 | -- |
| Arcoma AB | 132.94m | 4.35m | 113.90m | 31.00 | 24.83 | 1.55 | 9.83 | 0.8567 | 0.3205 | 0.3205 | 9.87 | 5.13 | 1.45 | 2.92 | 13.71 | 4,288,452.00 | 4.75 | 2.16 | 6.66 | 3.75 | 40.45 | 37.95 | 3.27 | 1.40 | 2.04 | -- | 0.00 | 0.00 | -3.81 | 3.24 | 336.00 | 11.08 | -9.43 | -- |
| Immunovia AB (publ) | 785.00k | -125.52m | 114.08m | 9.00 | -- | -- | -- | 145.33 | -0.3569 | -0.3569 | 0.0024 | -0.021 | 0.0156 | -- | 0.264 | 87,222.22 | -249.16 | -48.08 | -827.53 | -52.27 | -7,231.59 | -6,932.30 | -15,989.68 | -17,625.51 | 0.6282 | -3.00 | 1.68 | -- | -40.89 | 21.20 | 75.26 | -- | -- | -- |
| Scandinavian Real Heart AB | 0.00 | -38.87m | 139.46m | 12.00 | -- | 0.8356 | -- | -- | -16.17 | -16.17 | 0.00 | 16.69 | 0.00 | -- | -- | 0.00 | -44.53 | -27.49 | -52.77 | -30.65 | -- | -- | -- | -12,518.77 | -- | -- | 0.0678 | -- | -- | -- | 49.47 | -- | 6.59 | -- |
| Scandinavian Medical Solutions A/S | 350.63m | 37.14k | 144.20m | 28.00 | 5,500.00 | 1.22 | 11.53 | 0.4112 | 0.0007 | 0.0007 | 8.88 | 2.99 | 1.29 | 1.94 | 11.19 | -- | 0.0137 | 6.59 | 0.0246 | 11.68 | 23.12 | 24.88 | 0.0106 | 4.68 | 0.3524 | 1.14 | 0.4345 | -- | 8.28 | 42.38 | -99.67 | -64.34 | -- | -- |
| iZafe Group AB | 5.99m | -16.68m | 147.95m | 10.00 | -- | 12.68 | -- | 24.70 | -0.0497 | -0.0497 | 0.0178 | 0.0315 | 0.2002 | 4.03 | 8.65 | 599,100.00 | -55.71 | -66.81 | -91.50 | -83.32 | -74.75 | -303.52 | -278.35 | -762.55 | 0.47 | -2,397.57 | 0.0054 | -- | -24.68 | -7.62 | 18.69 | -- | -- | -- |
| Ortivus AB | 75.91m | -24.74m | 148.69m | 34.00 | -- | -- | -- | 1.96 | -0.5583 | -0.5583 | 1.71 | -0.5062 | 1.18 | 6.77 | 16.22 | 2,372,281.00 | -38.46 | -4.62 | -147.30 | -8.65 | 34.79 | 41.27 | -32.59 | -3.55 | 0.4719 | -4.01 | 1.72 | -- | -4.36 | 9.60 | -36.49 | -- | 65.37 | -- |
| Bactiquant A/S | 11.80m | -18.69m | 155.99m | -- | -- | 10.69 | -- | 13.22 | -0.4696 | -0.4696 | 0.2966 | 0.2723 | 0.4656 | 2.69 | 15.14 | -- | -73.73 | -55.41 | -85.85 | -64.53 | -31.80 | -10.94 | -158.37 | -121.81 | 3.26 | -9.70 | 0.1926 | -- | -41.68 | -14.27 | -4.72 | -- | -- | -- |
Data as of Feb 20 2026. Currency figures normalised to Iconovo AB's reporting currency: Swedish Krona SEK
0.74%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Fj�rde AP-fondenas of 30 Jun 2025 | 392.75k | 0.74% |
| Cicero Fonder ABas of 30 Jan 2026 | 0.00 | 0.00% |
Data from 31 Dec 2025 - 30 Jan 2026Source: FactSet Research Systems Inc.
